Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_assertion type Assertion NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_head.
- NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_assertion description "[During the screening phase, we identified ten miRNAs, eight of which (miR-20a-5p, miR-25-3p, miR-30a-5p, miR-92a-3p, miR-132-3p, miR-185-5p, miR-320a and miR-324-3p) were significantly overexpressed in the HBV-positive HCC patients compared with the HBV-positive cancer-free controls in both the training and validation sets, with a sensitivity of 0.866 and specificity of 0.646.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_provenance.
- NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_assertion evidence source_evidence_literature NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_provenance.
- NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_assertion SIO_000772 25845839 NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_provenance.
- NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_assertion wasDerivedFrom befree-2016 NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_provenance.
- NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_assertion wasGeneratedBy ECO_0000203 NP1276102.RAvt-mT-NlC4tA3YbMk5Yx-KbCDwUMsKq180-EXooHSgk130_provenance.